Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Investing Activities (2021 - 2025)

Core Scientific's Cash from Investing Activities history spans 5 years, with the latest figure at -$277.8 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 864.54% year-over-year to -$277.8 million; the TTM value through Dec 2025 reached -$740.8 million, down 678.16%, while the annual FY2025 figure was -$740.8 million, 678.16% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$277.8 million at Core Scientific, down from -$254.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.4 million in Q4 2023 and bottomed at -$308.3 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$31.6 million (2024), against an average of -$92.7 million.
  • The largest annual shift saw Cash from Investing Activities soared 101.69% in 2023 before it crashed 3656.53% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$308.3 million in 2021, then soared by 54.76% to -$139.5 million in 2022, then skyrocketed by 101.69% to $2.4 million in 2023, then tumbled by 1320.25% to -$28.8 million in 2024, then plummeted by 864.54% to -$277.8 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Cash from Investing Activities are -$277.8 million (Q4 2025), -$254.4 million (Q3 2025), and -$119.6 million (Q2 2025).